Send to a Friend Font Size: Increase Decrease

Viking Global Investors

Viking Global Investors 's Portfolio

Last Updated on 5/16/11 @ 05:55pm

Ticker	# of Shares	Price	Value
	143,085,126	$195.32	$27,947,386,811
	120,000,000	$195.32	$23,438,400,000
	75,238,700	$195.32	$14,695,622,884
GE	7,138,176	$323.11	$2,306,416,048
V	7,140,286	$317.36	$2,266,041,165
	9,798,229	$195.32	$1,913,790,089
MU	4,424,339	$370.30	$1,638,332,732
PM	9,055,492	$169.98	$1,539,252,531
	6,639,199	$195.32	$1,296,768,349
	6,524,565	$195.32	$1,274,378,036
View Additional Portfolio Information »

Viking Global Investors is a long/short equity hedge fund. The fund employs a bottom-up fundamental stock-picking strategy for its investments in equities in the U.S. and Europe. It focuses on the financial, telecommunication, media, technology, and consumer sectors. Viking Global Investors is based in New York and was founded in October, 1999 by Andreas Halvorsen, David Ott, and Brian Olson.

Messers. Halvorsen, Ott, and Olson worked together at Tiger Management Corp. All three left Tiger in early 1999.

Login to help us fill in information about this entity.

Form SC 13G/A 4D Molecular Therapeutic Filed by: VIKING GLOBAL INVESTORS LP Nov 14, 2024 04:32PM

Form SC 13G/A 4D Molecular Therapeutic Filed by: VIKING GLOBAL INVESTORS LP Jan 8, 2024 04:15PM

Form SC 13G/A 4D Molecular Therapeutic Filed by: VIKING GLOBAL INVESTORS LP Jan 8, 2024 04:05PM

Form 4 4D Molecular Therapeutic For: Jan 04 Filed by: Viking Global Opportunities GP LLC Jan 5, 2024 05:45PM

Form 4 4D Molecular Therapeutic For: May 09 Filed by: Viking Global Opportunities GP LLC May 11, 2023 05:51PM

Feb 14, 2022 06:25PM Form SC 13G/A 4D Molecular Therapeutic Filed by: VIKING GLOBAL INVESTORS LP
Feb 16, 2021 06:24AM Form SC 13G/A 4D Molecular Therapeutic Filed by: VIKING GLOBAL INVESTORS LP
Dec 21, 2020 05:28PM Form SC 13G 4D Molecular Therapeutic Filed by: VIKING GLOBAL INVESTORS LP

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed